JAMA Internal Medicine· 2016Q1

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

Benjamin Lazarus, Yuan Chen, F. Perry Wilson, Yingying Sang et al.

721citations
Q1SCImago
2016year

Short summary

Proton pump inhibitor (PPI) use is associated with a 35-50% increased risk of developing chronic kidney disease (CKD), with twice-daily dosing showing a higher risk than once-daily.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Gastroenterology

GastroenterologyMedicine